Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02663479 · ClinicalTrials.gov registry record · Phase 1

Nutraceutical Supplement in the Management of Hypertension

A Phase 1 study of Hypertension, sponsored by Thorne HealthTech.

Completed
Registry status
Phase 1
Development phase
40
Enrollment target
1
Study location

NCT02663479 is a Phase 1 study of Hypertension that has completed, run by Thorne HealthTech. The registered enrollment target is 40 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02663479, a Phase 1 study of Hypertension, has completed, sponsored by Thorne HealthTech.

COMPLETED
Registry status
Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the efficacy and safety of a proprietary nutraceutical supplement in capsule form over 4 months in treating blood pressure in a group of chronic hypertensive subjects that are not receiving any pharmaceutical anti-hypertensive agents or other nutraceutical supplements.

Conditions Studied

Hypertension

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Cardiopressin

Study Locations (1)

Tennessee

  • Hypertension Institute of Nashville, TN - Nashville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-09
Est. Completion 2017-10
Phase Phase 1

Sponsor

Thorne HealthTech

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02663479

The ClinicalTrials.gov registry entry for NCT02663479 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Thorne HealthTech, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02663479 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02663479 about?

NCT02663479 is a clinical study titled "Nutraceutical Supplement in the Management of Hypertension". The purpose of this study is to evaluate the efficacy and safety of a proprietary nutraceutical supplement in capsule form over 4 months in treating blood pressure in a group of chronic hypertensive subjects that are not receiving any pharmaceutical anti-hypertensive agents or other nutraceutical su...

What is the current status of trial NCT02663479?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2015-09. Estimated completion is 2017-10.

What conditions does trial NCT02663479 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT02663479?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Cardiopressin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02663479?

This trial is sponsored by Thorne HealthTech, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02663479 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.